Skip navigation

News & Events

Keep up to date on AgNovos events and related news

Archive - News

AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE

AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.

Corporate Rebranding Announcement

AgNovos Healthcare Announces Corporate Renaming as AgNovos Bioscience

AgNovos Healthcare to participate in 2022 British Orthopaedic Association Congress

AgNovos Healthcare is pleased to participate in this year’s British Orthopaedic Association Congress (BOA) from September 20-23 in Birmingham, England.

AgNovos Healthcare to Participate in German Society for Geriatric Traumatology Congress (Alterstraumatologie)

2022 ESCEO-AgNovos Young Investigator Award

It is with great pleasure that AgNovos Healthcare announces the recipients of this year’s ESCEO-AgNovos Young Investigator Award presented at World Congress on Osteoporosis in March 2022.

AgNovos Healthcare Completes Enrollment for CONFIRM Clinical Study

AgNovos Healthcare is pleased to announce the completion of enrollment for its CONFIRM clinical study.